H. Lôo

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

H. Lôo, A. Hale, H. D’haenen, 2002, International clinical psychopharmacology.

Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*

H. Lôo, M. Ansseau, J. A. Costa e Silva, 1999, Human psychopharmacology.

Effects of antidepressants on cognitive functions: A review

A. Galinowski, H. Lôo, A. Galinowski, 1995, Neuroscience & Biobehavioral Reviews.